Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma, Kaposi 3Epstein-Barr Virus Infections 2Acquired Immunodeficiency Syndrome 2Sarcoma 1Pyloric Stenosis, Hypertrophic 1Nasopharyngeal Carcinoma 1Multi-centric Castleman's Disease 1Lymphoproliferative Disorders 1Immune Reconstitution Inflammatory Syndrome 1Cytomegalovirus Infections 1Castleman Disease 1

Interventions

letermovir 1Valganciclovir 1Valacyclovir 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Cytomegalovirus Infections × Valganciclovir × Clear all
NCT01972035 2022-04-12

ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation

University of Minnesota

Phase 2 Completed
137 enrolled 8 charts

Cytomegalovirus Infections, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡